Common stockholders don't have a lot of protection in bankruptcy court.  Their fate is often dependent on how much creditors desire to squeeze the company, and many times common shares are wiped out. Gambling on these situations is not my cup of tea, but for Biovest (BVTI.PK) shareholders the gamble paid off.  Today, Biovest announced [...]

Getting a lot of emails and comments on Biovest and Accentia.  Some suggest that I need to do more homework on the bankruptcy proceedings for these two companies, and I couldn’t agree more.  As I pointed out in the earlier post, I am uncomfortable trading this without a solid understanding of the plans of reorganization [...]

Every year about this time, the biotech and pharma world turns its focus to the annual American Society of Clinical Oncologist (ASCO).  I’m told by a few readers who concentrate in these stocks that the hit from this year’s meeting was a tiny pink sheet stock called Biovest (BVTI.PK). Biovest presented in the plenary session of ASCO [...]